Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 4
1980 1
1981 1
1982 1
1983 1
1984 1
1985 2
1986 1
1987 5
1988 4
1989 4
1990 7
1991 10
1992 6
1993 8
1994 6
1995 8
1996 1
1997 6
1998 8
1999 6
2000 11
2001 13
2002 16
2003 6
2004 4
2005 7
2006 4
2007 5
2008 8
2009 4
2010 9
2011 11
2012 14
2013 17
2014 12
2015 14
2016 18
2017 20
2018 13
2019 11
2020 16
2021 14
2022 34
2023 34
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Los-Arcos I, Iacoboni G, Aguilar-Guisado M, Alsina-Manrique L, Díaz de Heredia C, Fortuny-Guasch C, García-Cadenas I, García-Vidal C, González-Vicent M, Hernani R, Kwon M, Machado M, Martínez-Gómez X, Maldonado VO, Pla CP, Piñana JL, Pomar V, Reguera-Ortega JL, Salavert M, Soler-Palacín P, Vázquez-López L, Barba P, Ruiz-Camps I. Los-Arcos I, et al. Infection. 2021 Apr;49(2):215-231. doi: 10.1007/s15010-020-01521-5. Epub 2020 Sep 26. Infection. 2021. PMID: 32979154 Free PMC article. Review.
We reviewed the literature on the incidence, risk factors, and management of infections in adult and pediatric patients receiving CAR-T cell treatment. Recommendations cover different areas: monitoring and treatment of hypogammaglobulinemia, prevention, prophylaxis, and ma …
We reviewed the literature on the incidence, risk factors, and management of infections in adult and pediatric patients receiving CAR …
The "Choosing Wisely" initiative in infectious diseases.
Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV, Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ, Fätkenheuer G, Jung N. Lehmann C, et al. Infection. 2017 Jun;45(3):263-268. doi: 10.1007/s15010-017-0997-0. Epub 2017 Mar 13. Infection. 2017. PMID: 28290130 Review.
COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, Rabaan AA, Al-Omari A, Tirupathi R, AlQahtani M, AlBahrani S, Dhama K. Al-Tawfiq JA, et al. Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24. Infection. 2021. PMID: 34302291 Free PMC article. Review.
Can microalbuminuria be an indicator of renal involvement in pediatric Covid 19 patients?
Özlü SG, Aydın Z, Bozelli BN, Avcı B, İnözü M, Çaycı FŞ, Gülhan B, Sezer S, Bayrakçı US. Özlü SG, et al. Infection. 2022 Jun;50(3):719-724. doi: 10.1007/s15010-021-01745-z. Epub 2022 Jan 30. Infection. 2022. PMID: 35094314 Free PMC article.
However currently studies addressing proteinuria and its role in the outcome of kidney and patients of pediatric COVID 19 is scarce. We aimed to evaluate the presence of microalbuminuria in order to detect early renal involvement in pediatric COVID 19 patients. METH …
However currently studies addressing proteinuria and its role in the outcome of kidney and patients of pediatric COVID 19 is scarce. …
Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland.
Scheler M, Lehrnbecher T, Groll AH, Volland R, Laws HJ, Ammann RA, Agyeman P, Attarbaschi A, Lux M, Simon A. Scheler M, et al. Infection. 2020 Aug;48(4):607-618. doi: 10.1007/s15010-020-01462-z. Epub 2020 Jun 10. Infection. 2020. PMID: 32524514 Free PMC article.
PURPOSE: Investigation of the current practice of diagnostics and treatment in pediatric cancer patients with febrile neutropenia. METHODS: On behalf of the German Society for Pediatric Oncology and Hematology and the German Society for Pediatric Infectious D …
PURPOSE: Investigation of the current practice of diagnostics and treatment in pediatric cancer patients with febrile neutropenia. ME …
Nosocomial pneumonia in children.
Jacobs RF. Jacobs RF. Infection. 1991 Mar-Apr;19(2):64-72. doi: 10.1007/BF01645570. Infection. 1991. PMID: 2050423 Review.
Unfortunately, these treatment modalities and preventive measures have not kept pace with our understanding of the pathogenesis of this infection. The pediatric patient population presents several unique and specific infection control, diagnostic and treatment problems for …
Unfortunately, these treatment modalities and preventive measures have not kept pace with our understanding of the pathogenesis of this infe …
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature.
Oliva A, Siccardi G, Migliarini A, Cancelli F, Carnevalini M, D'Andria M, Attilia I, Danese VC, Cecchetti V, Romiti R, Ceccarelli G, Mastroianni CM, Palange P, Venditti M. Oliva A, et al. Infection. 2020 Dec;48(6):871-877. doi: 10.1007/s15010-020-01483-8. Epub 2020 Jul 28. Infection. 2020. PMID: 32725598 Free PMC article. Review.
Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far. ...
Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoni …
Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.
Tuon FF, Rocha JL, Formigoni-Pinto MR. Tuon FF, et al. Infection. 2018 Apr;46(2):165-181. doi: 10.1007/s15010-017-1096-y. Epub 2017 Nov 7. Infection. 2018. PMID: 29110143 Review.
Ceftazidime-avibactam has been evaluated versus meropenem/doripenem in hospitalized adults with nosocomial pneumonia, neutropenic patients and pediatric patients. CONCLUSION: Ceftazidime-avibactam has a favorable pharmacokinetic profile for severe infections and highly act …
Ceftazidime-avibactam has been evaluated versus meropenem/doripenem in hospitalized adults with nosocomial pneumonia, neutropenic patients a …
355 results